<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-vaccines-08-00531">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Oliveira</surname>
    <given-names>V.L.</given-names>
   </name>
   <name>
    <surname>Almeida</surname>
    <given-names>S.C.P.</given-names>
   </name>
   <name>
    <surname>Soares</surname>
    <given-names>H.R.</given-names>
   </name>
   <name>
    <surname>Crespo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Marshall-Clarke</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Parkhouse</surname>
    <given-names>R.M.E.</given-names>
   </name>
  </person-group>
  <article-title>A novel TLR3 inhibitor encoded by African swine fever virus (ASFV)</article-title>
  <source>Arch. Virol.</source>
  <year>2011</year>
  <volume>156</volume>
  <fpage>597</fpage>
  <lpage>609</lpage>
  <pub-id pub-id-type="doi">10.1007/s00705-010-0894-7</pub-id>
  <?supplied-pmid 21203785?>
  <pub-id pub-id-type="pmid">21203785</pub-id>
 </element-citation>
</ref>
